Provided by Tiger Fintech (Singapore) Pte. Ltd.

WAVE Life Sciences

6.93
-0.2900-4.02%
Volume:238.64K
Turnover:1.68M
Market Cap:1.07B
PE:-9.04
High:7.32
Open:7.32
Low:6.86
Close:7.22
Loading ...

Company Profile

Company Name:
WAVE Life Sciences
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
288
Office Location:
Marina One East Tower,7 Straits View No.12-00,Singapore,Singapore
Zip Code:
018936
Fax:
- -
Introduction:
Wave Life Sciences Ltd., a clinical-stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid (RNA) to correct disease-causing mutations, modulate protein activity, restore the production of functional proteins, or reduce the expression of disease-promoting RNAs or proteins. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; WVE-006, the SERPINA1 molecule for the treatment of Alpha-1 antitrypsin deficiency (AATD); and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders, including Alzheimer's and Parkinson's diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, and Glaxo Group Limited. The company was incorporated in 2012 and is based in Singapore.

Directors

Name
Position
Christian Henry
Chairman of the Board
Paul B. Bolno
President,Chief Executive Officer and Director
Adrian Rawcliffe
Director
Aik Na Tan
Director
Gregory L. Verdine
Director
Heidi L. Wagner
Director
Ken Takanashi
Director
Mark H. N. Corrigan
Director
Peter Kolchinsky
Director

Shareholders

Name
Position
Paul B. Bolno
President,Chief Executive Officer and Director
Christopher Francis
Senior Vice President, Corporate Development, Head of Emerging Areas
Kyle Moran
Chief Financial Officer
Chandra Vargeese
Chief Technology Officer, Head of Platform Discovery Sciences